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D. G. Llewellyn Comment I 
be carried out by a competent person. Many of these procedures are not daily 
tasks, such as tusk removal in boars or ringing of bulls. On the horizon one sees 
many objectionable maimings such as amputation of the penis in vasectomized 
bulls to prevent intromission, amputation of the tongue in calves, and the possi-
ble insertion of electronic transponders in cattle. This is an area where we must 
not abdicate our responsibilities. The role of the practitioner must continue in the 
future to safeguard the well-being of our livestock by giving advice on care and 
the prevention of neglect, as well as therapy to the sick and injured. 
Welfare is team work. The practitioners will do the forward work, the half 
back District Veterinary Offices will be at hand in any difficult situation, sup-
ported by the talents of Agricultural Development and Advisory Service (ADAS) 
in the center and the universities on the wings. Very few problems should ever 
reach the Minister of Agriculture at full back, but if one ever does let us hope he 
will not put it out of play into touch, but give us an 'up and under' so that we can 
all bring our expertise together to solve the problem. 
Laboratory Animals and 
Alternatives in the 80's 
Andrew N. Rowan 
Introduction 
In 1969, Sir Peter Medewar, immunologist, Nobel prize-winner and philoso-
pher of science, made the following statement at the Research Defence Society's 
Annual Meeting: 
162 
The use of animals in laboratories to enlarge our understand-
ing of nature is part of a far wider exploratory process, and 
one cannot assay its value in isolation- as if it were an ac-
tivity which, if prohibited, would deprive us only of the 
material benefits that grow directly out of its own use. Any 
such prohibition of learning or confinement of the under-
standing would have widespread and damaging conse-
quences; but this does not imply that we are forevermore, 
and in increasing numbers, to enlist animals in the scientific 
service of man. I think that the use of experimental animals 
on the present scale is a temporary episode in biological and 
medical history, and that its peak will be reached in ten years 
time, or perhaps even sooner. In the meantime, we must 
grapple with the paradox that nothing but research on 
animals will provide us with the knowledge that will make it 
possible for us, one day, to dispense with the use of them 
altogether (Medewar, 1972). 
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It is now just over ten years since Medewar made the prediction that the 
number of laboratory animals used every year would peak. Figures produced by 
the U.K. authorities indicate that he was more or less correct. Although the num-
ber of recorded animal experiments in the U.K. has stabilized around 5.4 million 
per annum and may even be falling, it is by no means clear whether this is due to 
reduced funding and the increasing expense of laboratory animals or to the 
development and adoption of alternatives (see Box). The most likely explanation 
is that this peaking is the result of a combination of these and related factors. 
Whatever the reason, we are entering the 80's amid a flurry of interest in and ac-
tivity around the idea of "alternatives to laboratory animals." 
In this discussion, an alternative is defined as any technique which 
could: 
• REPLACE the use of animals altogether; 
• REDUCE the numbers of animals required; 
• reduce the amount of stress suffered by the animal by 
REFINING the techniques used. 
At the same time, and this is most important, any alternative system must 
provide data which leads to the same ultimate conclusion with the same 
or greater degree of confidence as that obtained from the method being 
replaced. 
A clear example of this concept is provided by the experience of an 
anti-viral screening program in a major pharmaceutical company 
(Bucknall, R.A., 1980, The use of cultured cells and tissues in the 
development of anti-viral drugs. In The Use of Alternatives in Drug 
Research [eds A.N. Rowan and C.J. Stratmann] MacMillan: London, pp. 
15-27). Over a period of fifteen years (up to 1977), the introduction of cell 
and organ culture screening techniques reduced the number of mice re-
quired per annum from approximately 13,000 to about 2,000. At the same 
time, the company was able to increase the number of compounds 
screened for potential anti-viral properties from about 2,000 to about 
24,000 per annum. There are a couple of instructive points in this exam-
ple. First, the laboratory reduced rather than eliminated the use of mice. 
The cell and organ culture systems could not mimic mammalian 
·metabolism completely and, therefore, the final screening tests still had 
to be conducted in the whole animal. Second, a great deal of time and 
money was saved by doing the initial screening of compounds with 
unknown potential in the faster and cheaper cell system. However, 
although the time and cost benefits of alternative systems are indisputa-
ble, scientists do not always agree that the conclusions derived from 
them are as valid as those derived from the animal system. 
Europe 
In Europe, the interest in alternatives has grown steadily ever since the 
Council of Europe adopted Recommendation 621 in 1971. (The Council of Europe 
is a loosely-knit treaty organization of 21 European countries). This Recommen-
dation was a radical document which, inter alia, called for the drafting of interna-
tional legislation to set out the conditions under which experiments on live ani-
/NT 1 STUD ANIM PROB 1(3] 1980 163 
D. G. Llewellyn Comment I 
be carried out by a competent person. Many of these procedures are not daily 
tasks, such as tusk removal in boars or ringing of bulls. On the horizon one sees 
many objectionable maimings such as amputation of the penis in vasectomized 
bulls to prevent intromission, amputation of the tongue in calves, and the possi-
ble insertion of electronic transponders in cattle. This is an area where we must 
not abdicate our responsibilities. The role of the practitioner must continue in the 
future to safeguard the well-being of our livestock by giving advice on care and 
the prevention of neglect, as well as therapy to the sick and injured. 
Welfare is team work. The practitioners will do the forward work, the half 
back District Veterinary Offices will be at hand in any difficult situation, sup-
ported by the talents of Agricultural Development and Advisory Service (ADAS) 
in the center and the universities on the wings. Very few problems should ever 
reach the Minister of Agriculture at full back, but if one ever does let us hope he 
will not put it out of play into touch, but give us an 'up and under' so that we can 
all bring our expertise together to solve the problem. 
Laboratory Animals and 
Alternatives in the 80's 
Andrew N. Rowan 
Introduction 
In 1969, Sir Peter Medewar, immunologist, Nobel prize-winner and philoso-
pher of science, made the following statement at the Research Defence Society's 
Annual Meeting: 
162 
The use of animals in laboratories to enlarge our understand-
ing of nature is part of a far wider exploratory process, and 
one cannot assay its value in isolation- as if it were an ac-
tivity which, if prohibited, would deprive us only of the 
material benefits that grow directly out of its own use. Any 
such prohibition of learning or confinement of the under-
standing would have widespread and damaging conse-
quences; but this does not imply that we are forevermore, 
and in increasing numbers, to enlist animals in the scientific 
service of man. I think that the use of experimental animals 
on the present scale is a temporary episode in biological and 
medical history, and that its peak will be reached in ten years 
time, or perhaps even sooner. In the meantime, we must 
grapple with the paradox that nothing but research on 
animals will provide us with the knowledge that will make it 
possible for us, one day, to dispense with the use of them 
altogether (Medewar, 1972). 
/NT 1 STUD ANIM PROB 1(3) 1980 
A.N.Rowan Comment I 
It is now just over ten years since Medewar made the prediction that the 
number of laboratory animals used every year would peak. Figures produced by 
the U.K. authorities indicate that he was more or less correct. Although the num-
ber of recorded animal experiments in the U.K. has stabilized around 5.4 million 
per annum and may even be falling, it is by no means clear whether this is due to 
reduced funding and the increasing expense of laboratory animals or to the 
development and adoption of alternatives (see Box). The most likely explanation 
is that this peaking is the result of a combination of these and related factors. 
Whatever the reason, we are entering the 80's amid a flurry of interest in and ac-
tivity around the idea of "alternatives to laboratory animals." 
In this discussion, an alternative is defined as any technique which 
could: 
• REPLACE the use of animals altogether; 
• REDUCE the numbers of animals required; 
• reduce the amount of stress suffered by the animal by 
REFINING the techniques used. 
At the same time, and this is most important, any alternative system must 
provide data which leads to the same ultimate conclusion with the same 
or greater degree of confidence as that obtained from the method being 
replaced. 
A clear example of this concept is provided by the experience of an 
anti-viral screening program in a major pharmaceutical company 
(Bucknall, R.A., 1980, The use of cultured cells and tissues in the 
development of anti-viral drugs. In The Use of Alternatives in Drug 
Research [eds A.N. Rowan and C.J. Stratmann] MacMillan: London, pp. 
15-27). Over a period of fifteen years (up to 1977), the introduction of cell 
and organ culture screening techniques reduced the number of mice re-
quired per annum from approximately 13,000 to about 2,000. At the same 
time, the company was able to increase the number of compounds 
screened for potential anti-viral properties from about 2,000 to about 
24,000 per annum. There are a couple of instructive points in this exam-
ple. First, the laboratory reduced rather than eliminated the use of mice. 
The cell and organ culture systems could not mimic mammalian 
·metabolism completely and, therefore, the final screening tests still had 
to be conducted in the whole animal. Second, a great deal of time and 
money was saved by doing the initial screening of compounds with 
unknown potential in the faster and cheaper cell system. However, 
although the time and cost benefits of alternative systems are indisputa-
ble, scientists do not always agree that the conclusions derived from 
them are as valid as those derived from the animal system. 
Europe 
In Europe, the interest in alternatives has grown steadily ever since the 
Council of Europe adopted Recommendation 621 in 1971. (The Council of Europe 
is a loosely-knit treaty organization of 21 European countries). This Recommen-
dation was a radical document which, inter alia, called for the drafting of interna-
tional legislation to set out the conditions under which experiments on live ani-
/NT 1 STUD ANIM PROB 1(3] 1980 163 
A.NRowan Comment I 
mals may be authorized and, specifically, for the establishment of a major inter-
national clearinghouse on alternatives. At present, the Council of Europe's expert 
committee is completing a draft treaty on laboratory animals which is con-
siderably watered down from the original Recommendation. Interest in alterna-
tives has, in the meantime, grown significantly, and several of the European na-
tions have publicly supported the concept. 
In Britain, Mr. Callaghan, as Prime Minister, issued the following answer to a 
question in Parliament about his Government's intentions vis-a-vis alternatives: 
I hope I have indicated that it would certainly be our policy 
and desire to move to alternatives to animal experiments as 
quickly as possible, and our efforts must be directed in that 
way [Hansard, 8 Dec 1977, Cots 1642-1644). 
The Home Office (which administers The Cruelty to Animals Act, 1876) backed 
up the Prime Minister's statement by sending out a letter exhorting all scientists 
in Britain who are licensed to perform experiments on living animals to "take 
every reasonable step to confirm, before using living animals, that their investiga-
tions" could not be effectively carried out by other means. The letter continued 
by urging the licensees "to give thought to the possibilities of developing new 
alternatives to the use of living animals and to publishing information about suc-
cessful new methods." According to reports, this letter caused some resentment 
among biomedical researchers, but it certainly demonstrated the Government's 
public commitment to the idea. 
In continental Europe, the Federal Republic of Germany included a section 
on alternatives in its Animal Protection Law of 1972 which stated that potentially 
injurious experimentation would only be authorized if the research could not be 
done on nonanimal systems or on phyletically lower animals. In Denmark, the 
1953 law on experimental animals was amended on May 13,1977 to forbid pain-
ful experiments in schools and to allow experiments on live animals only after 
due permission is obtained from a national committee composed of four scien-
tists, a lawyer and three representatives from the Danish Society for the Preven-
tion of Cruelty to Animals. Also in 1977, the Dutch Parliament enacted legislation 
which placed heavy emphasis on the requirement that those dealing with 
laboratory animals have adequate professional skill and that "no animal experi-
ment shall be conducted for a purpose that, according to the consensus of opin-
ion among experts, could equally well be achieved in some other way." At last 
year's (1979) meeting of the International Committee for Laboratory Animal 
Science in Utrecht, the Dutch Minister of Health and Enviromental Protection, 
Dr. Ginjaar, drew specific attention to this point and stated that "The 
Netherlands endorses a suggestion made in the Council of Europe's Committee of 
Experts on the Protection of Animals that the matter of alternatives be promoted 
at the European level." 
Outside the European Economic Community (EEC), Sweden has recently 
established a governmental advisory Central Committee on Experimental 
Animals, one of whose responsibilities is the development and promotion of 
alternatives. Approximately $90,000 has been distributed to research projects 
dealing with alternatives, and a section on alternatives is to be included in a 
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course for veterinary students this year. Sweden also passed a law at the end of 
1978 making reviews of animal experiments by ethical committees in government 
institutions mandatory. Elsewhere, the Swiss Federal Assembly passed a new 
animal welfare law in December 1978 which is expected to be put into force in 
mid-1980. 
Animal welfare and anti-vivisection societies in Europe are not only en-
couraged by recent government activity, but are themselves encouraging scien-
tists to consider the concept of alternatives by making grant money available for 
research. One such organization in Britain, the Lord Dowding Fund for Humane 
Research, held a meeting in the last quarter of 1979 to discuss the results of 
research which it has been supporting (New Scientist 84:271-272, 1979). As is not 
uncommon in scientific progress, the results were rather mixed. 
Dr. Derek Calam of the National Institute for Biological Standards and Con-
trol (London) has been working on a high-performance liquid chromatography 
(HPLC) method for assaying "biological medicines" such as insulin and oxytocin 
which are currently standardized in potency assays using animals. However, 
Calam is having difficulty obtaining reproducible results although the HPLC 
method is potentially sensitive enough (±3% accuracy) to meet the regulatory 
requirements of ±10% accuracy for oxytocin potency assays. 
Dr. Peter Knox of St. George's Hospital Medical School (London) is studying 
the nutrient requirements of cells in culture. He argues that cell culture 
technology is still in its infancy and needs to be improved so that it may become 
a more useful alternative. The blood serum supplement, which normally is added 
to cell culture nutrient media, contains a large number of constitutents, most of 
which are unidentified. It is not known which constituents, and in what combina-
tion, are essential to normal cell growth. Knox has been working on this very com-
plex problem and has isolated two proteins which appear to play a role in cell 
adhesion to the petri dish, a vital step in the growth process, and is following up 
on this finding. 
Research on these or similar techniques is, of course, being supported by 
establishment organizations. However, the animal welfare trusts serve to focus 
attention on the potential of these techniques as alternatives. 
The United States-Arguing the "Alternatives" Concept 
The idea of alternatives is coming of age in Europe, but progress in the 
United States is a little slower. There have been one or two meetings at which the 
subject has been addressed- notably the ConMed Symposium in Cincinnati last 
year organized by the Department of Laboratory Animal Medicine at the Univer-
sity of Cincinnati. The National Institutes of Health is also considering a proposal 
to hold a major conference on the topic. 
Furthermore, following the success of the Lord Dowding Fund in Britain, an 
"alternatives" funding organization has been established in New York (American 
Fund for Alternatives to Animal Research [AFAAR], 175 West 12th Street, New 
York, NY 10011). On January 19,1980, AFAAR organized a small meeting at which 
two scientists who have received funds for alternatives research described their 
work. Professor Oscar Frank of the New jersey Medical School discussed his 
work on microbial vitamin and amino acid assays, their potential for studying 
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vitamin deficiency disorders, and the role played by drug anti-metabolites. One 
protozoan, Tetrahymena pyriformis has the same amino acid requirements as 
man and the rat (the usual laboratory animal for testing protein quality). Pro-
fessor Frank and his group have developed a technique which allows them to use 
the protozoan rather than the rat as the test animal for protein quality, and 
AFAAR is funding research into other applications of the assay. Dr John Petrie-
ciani of the Food and Drug Administration's Bureau of Biologics and scientific 
advisor to AFAAR, described research in his laboratory to develop an organ 
culture assay (using chick embryonic skin) to measure the tumorigenic potential 
of cells. Usually, tumorigenic potential is assessed in an immunosuppressed 
animal or in the nude mouse, but Petricciani argues that the chick embryonic skin 
test is more sensitive, quicker and less expensive than the animal test. He also 
stated that there are other areas where animal models are still required; e.g., to 
assess the metastasis (spreading) potential of a tumor. 
·Despite these developments, many American research scientists still express 
some uneasiness about the concept of alternatives. A frequent argument is that 
one cannot predict the outcome of research and, therefore, allocating funds for 
the development of alternatives would be a mistake. This argument fails to take 
into account a number of features about research in general and the alternatives 
concept in particular. First, funds are allocated for particular areas of research in 
the hope that this will stimulate the generation of good ideas and research proj-
ects. Second, the development and application of new techniques is an important 
part of the research process and it frequently is possible to predict the benefits o_f 
better techniques. Conversely, the application of greater resources to a multi-
faceted research problem, in which not even the correct questions are known, 
can confound predictions. This is exemplified by the failure of the "war on 
cancer." 
The advance of biomedical knowledge depends on a number of factors in-
cluding an adequate reserve of imagination and intuition and sufficient funds, 
equipment and manpower for the critical evaluation and testing of new ideas. 
Imagination and critical review are the basis of the hypothetico-deductive model 
of scientific advance, but two other factors must also be included: luck and tech-
nique development. The importance of technique development is attested to_by 
the number of awards given to scientists who develop new methods for attackmg 
old problems. For example, Dr. Rosalyn Yalow received a Nobel price in 1977 for 
her part in the development of the radio-immunoassay technique. This technique 
has been cited as an alternative because it allows a researcher to assay very small 
amounts of complex biological molecules which previously could only have 
been done (if, indeed, it was possible at all) by using living animals. 
The alternative technique which has raised the highest hopes among animal 
welfare organizations is tissue culture. Bernard Dixon argues in his book, What Is 
Science For (Penguin, 1972, pg 31), that when medical researchers look back 
through the decades, they will select as one of the most important single devel-
opments in the 1960's the technical innovations leading to the growth and study 
of human cells in the laboratory. As stated earlier, the technique is still in its in-
fancy. If more research resources were devoted to improving and developing cell 
culture techniques, the investigation of many research problems would be simpli-
fied. For example, an understanding of the complete growth requirements of 
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human cells would probably have a major impact on our understanding of differ-
entiation and malignant growth. 
The National Institutes of Health already recognizes the importance of sup-
porting technical developments through its Biotechnology Resources program in 
the Division of Research Resources (ORR). The ORR provided $11.8 million in 
1976 to assist in the support and acquisition of complex technological capabili-
ties for qualified research scientists, but a 1976 report on the ORR mission (known 
as the Bolt, Beranek and Newman Report after the name of the consultancy or-
ganization which managed the review), had the following to say about the bio-
technology program: 
The Panel finds this program to be substantially under-
funded even for its current portfolio. Furthermore, the Bio-
technology Resources Board should address the challenges 
inherent in biotechnology needs by adding activities in new 
directions. Specifically, support should be given to pre-
resource development of biomedically-relevant technolo-
gies before they are mature enough to serve a user com-
munity. 
Therefore, the Bolt, Beranek and Newman report implicitly supports the idea of 
developing new techniques (which would include alternatives) and also argues 
that the ORR is not adequately fulfilling its function of conceiving and creating 
such new resources. The application of funds specifically to the deveiQpment of 
cell culture technology, to the training of scientists in tissue culture techniques 
and to the dissemination of appropriate information on all research models (not 
just animal models as is currently the case) would definitely fall within the pur-
view of the ORR. 
The ORR currently provides approximately $14 million per annum to main-
tain seven primate centers around the country. It is arguable that, if these funds 
had been devoted specifically to the development and application of cell culture 
technology, the subsequent advances in biomedical knowledge would have been 
more significant than those emanating from the primate centers. Animal welfare 
groups believe that there is too little attention paid to in vitro versus animal 
research models and are therefore attempting to direct research funds to the 
development and application of alternative techniques via congressional action. 
As a result, three Bills have been introduced into the U.S. House of Represen-
tatives in 1979. 
The United States-Legislative Activity 
The first Bill, H.R. 282, was introduced by Congressman Drinan (0-MA). This 
Bill is relatively straightforward and uncontroversial. It calls upon Congress to 
allocate $12 million to the development of alternative techniques. Most animal 
welfare advocates consider that the bill is too modest. The second Bill, H.R. 4479, 
was introduced by Congressman Weiss (0-NY), and it mandates the establishment 
of a Commission to study alternative methods to the use of live animals in 
research and testing. The Bill requires that individuals appointed to the Commis-
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of scientific advance, but two other factors must also be included: luck and tech-
nique development. The importance of technique development is attested to_by 
the number of awards given to scientists who develop new methods for attackmg 
old problems. For example, Dr. Rosalyn Yalow received a Nobel price in 1977 for 
her part in the development of the radio-immunoassay technique. This technique 
has been cited as an alternative because it allows a researcher to assay very small 
amounts of complex biological molecules which previously could only have 
been done (if, indeed, it was possible at all) by using living animals. 
The alternative technique which has raised the highest hopes among animal 
welfare organizations is tissue culture. Bernard Dixon argues in his book, What Is 
Science For (Penguin, 1972, pg 31), that when medical researchers look back 
through the decades, they will select as one of the most important single devel-
opments in the 1960's the technical innovations leading to the growth and study 
of human cells in the laboratory. As stated earlier, the technique is still in its in-
fancy. If more research resources were devoted to improving and developing cell 
culture techniques, the investigation of many research problems would be simpli-
fied. For example, an understanding of the complete growth requirements of 
166 /NT f STUD ANIM PROB 1(3) 1980 
A.N.Rowan Comment I 
human cells would probably have a major impact on our understanding of differ-
entiation and malignant growth. 
The National Institutes of Health already recognizes the importance of sup-
porting technical developments through its Biotechnology Resources program in 
the Division of Research Resources (ORR). The ORR provided $11.8 million in 
1976 to assist in the support and acquisition of complex technological capabili-
ties for qualified research scientists, but a 1976 report on the ORR mission (known 
as the Bolt, Beranek and Newman Report after the name of the consultancy or-
ganization which managed the review), had the following to say about the bio-
technology program: 
The Panel finds this program to be substantially under-
funded even for its current portfolio. Furthermore, the Bio-
technology Resources Board should address the challenges 
inherent in biotechnology needs by adding activities in new 
directions. Specifically, support should be given to pre-
resource development of biomedically-relevant technolo-
gies before they are mature enough to serve a user com-
munity. 
Therefore, the Bolt, Beranek and Newman report implicitly supports the idea of 
developing new techniques (which would include alternatives) and also argues 
that the ORR is not adequately fulfilling its function of conceiving and creating 
such new resources. The application of funds specifically to the deveiQpment of 
cell culture technology, to the training of scientists in tissue culture techniques 
and to the dissemination of appropriate information on all research models (not 
just animal models as is currently the case) would definitely fall within the pur-
view of the ORR. 
The ORR currently provides approximately $14 million per annum to main-
tain seven primate centers around the country. It is arguable that, if these funds 
had been devoted specifically to the development and application of cell culture 
technology, the subsequent advances in biomedical knowledge would have been 
more significant than those emanating from the primate centers. Animal welfare 
groups believe that there is too little attention paid to in vitro versus animal 
research models and are therefore attempting to direct research funds to the 
development and application of alternative techniques via congressional action. 
As a result, three Bills have been introduced into the U.S. House of Represen-
tatives in 1979. 
The United States-Legislative Activity 
The first Bill, H.R. 282, was introduced by Congressman Drinan (0-MA). This 
Bill is relatively straightforward and uncontroversial. It calls upon Congress to 
allocate $12 million to the development of alternative techniques. Most animal 
welfare advocates consider that the bill is too modest. The second Bill, H.R. 4479, 
was introduced by Congressman Weiss (0-NY), and it mandates the establishment 
of a Commission to study alternative methods to the use of live animals in 
research and testing. The Bill requires that individuals appointed to the Commis-
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sian should include representatives from animal welfare groups, biomedical 
research organizations and veterinarians. The Commission would have a max-
imum of five years for the investigation and an annual budget of not more than 
$750,000. 
The third and most recent Bill, H.R. 4805, was introduced on July 16,1979 
and is sponsored by Congressmen Richmond (D-NY), Roe (D-NJ), Hollenbeck 
(R-NJ) and Wolff (D-NY). It is based on a draft bill drawn up by United Action for 
Animals. This Bill mandates the establishment of a National Center for Alter-
native Research to increase the use of existing alternatives, to encourage the de-
velopment of more alternatives, to provide for the training of scientists in the use 
of such alternatives, to eliminate duplication and repetitive research on live 
animals, and to disseminate information on alternatives. The National Center, 
directed by representatives of all the federal agencies who fund animal research, 
would be required to publish an annual report of how the goals of the Bill are be-
ing met. Finally, the Bill mandates the re-allocation of 30-50% of all appropria-
tions for live animal research and testing to the development of alternatives. 
The presence of three bills in the House of Representatives promoting the 
idea of alternatives has generated widespread interest in the subject in the 
United States. For example, the General Accounting Office has been requested to 
investigate whether or not research would benefit from the allocation of funds 
specifically to the development of alternatives and the National Institutes of 
Health has been conducting its own in-house survey on the extent to which it cur-
rently funds research utilizing techniques which fall within the "alternatives" 
classification. However, scientific organizations are unenthusiastic about all of 
the Bills. Although the Drinan Bill (H.R. 282) is not controversial and would pro-
vide additional funding to scientists, an official letter from the Department of 
Health, Education and Welfare comments that, although the Department sup-
ports the purpose of this bill, it "questions the need for specific authorization." 
The National Institutes of Health and other scientific organizations are, not sur-
prisingly, much more strongly opposed to the more radical and sweeping H.R. 
4805. 
A major attraction of H.R. 4805 to members of the present Congress is that 
the Bill does not require additional funding. However, biomedical research fund-
ing agencies are unhappy about the restraints that the bill would place on their 
activities, and many regard it as being anti-science. United Action for Animals 
has publicized the Bill widely, and it has vocal support among members of 
animal welfare organizations, and support from some establishment sources. For 
example, the Christian Science Monitor carried an editorial about the Bill on 
October 25, 1979 in which they stated that "such legislation would not inhibit any 
essential research but might help foster a moral climate in which greater empha-
sis is placed on humane consideration of the life of all living creatures. It 
deserves public support." There has been a mixed response from the animal wel-
fare groups themselves. The Society for Animal Rights opposes the Bill because it 
"clearly implies that the vivisection of animals is acceptable and necessary until 
such time as alternatives are discovered and put into use" (SAR Report, 
December 1979). The Humane Society of the United States is committed to sup-
port for the principle of alternatives, but considers that H.R. 4805 will have to be 
modified if it is to have any chance of enactment against the opposition of the 
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very powerful research lobby. 
H.R. 4805 and the other Bills are serving a useful purpose in raising the con-
sciousness of the political public and in forcing scientific organizations to pay 
greater attention to the question of alternatives. It is not unlikely that some sort 
of "alternatives" bill could be passed in the next decade as the subject comes 
under closer and closer scrutiny. In order for such a bill to satisfy the animal wel-
fare community, it would have to contain elements which provided substantial 
funding for the development of alternatives, which provided for the training of 
scientists and the dissemination of relevant information, and which tackled the 
problems of unscientific duplication and repetitive research. On the other hand, 
if such a bill is to be acceptable to a reasonable proportion of biomedical re-
searchers, then it will have to be perceived as a constructive development. In 
fact, the research constituency is still apprehensive about the whole concept of 
alternatives and much groundwork is still required, employing technical and 
scholarly arguments, to persuade biomedical scientists that the concept is not 
only valid but that it can also be valuable. 
At the very least, generation of a positive attitude toward alternatives 
should lead to better planning of research and to the use of the most appropriate 
research models. At the very most, the development of in vitro research models 
can lead to significant new research opportunities. According to Professor Sergey 
Federoff, past president of the Tissue Culture Association, "the application of 
tissue cultures to biomedical research is limited only by the imagination of the 
scientists employing them." 
Dr. Rowan is the author of Alternatives to Laboratory Animals, 
which is a review of the scientific and technical aspects of alternatives 
and an examination of the potential and the limitations of the alter-
natives concept. The monograph contains detailed information on 
animal use in various types of biomedical research, a description of 
alternative techniques and their applicability to specific research 
areas, as well as extensive references and a selected bibliography 
covering the ethics, history and legal aspects of animal experimenta-
tion. Alternatives to Laboratory Animals is available at a cost of $2.00 
from the Institute for the Study of Animal Problems, 2100 L St. 1'-IW, 
Washington, DC 20037, USA. 
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